Paper - WANFANG MED ONLINE

You Position: Home > Paper

循环肿瘤细胞在卵巢上皮性癌中应用的研究进展

( views:164, downloads:212 )

Author:: No author available

Journal Title:: Chinese Journal of Obstetrics and Gynecology

Issue:: 12

DOI:: 10.3760/cma.j.issn.0529-567x.2014.12.016

Key Word:: No keyword available

Abstract：卵巢上皮性癌(卵巢癌)是病死率最高的妇科恶性肿瘤,早期患者的临床症状与体征不明显,约75％的卵巢癌患者就诊时已处于晚期,接受初始治疗有效的患者中约75％会复发,因此,尽管卵巢癌的诊治水平较以往有所提升,但其5年生存率较30年之前相比也只是从37％升高到46％[1].

Reference

[1]Pearl ML,Chen JJ,Chen WT,etc.Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.[J].2009,112(1).
[2]Eva, Obermayr,Fatima, Sanchez-Cabo,Muy-Kheng M, Tea,etc.Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.[J].2010,10.
[3]Gillet,B.,Loriot,V.,Molina,F.,etc.Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA[J].2014,20(4).
[4]Fischer, J.C.,Niederacher, D.,Topp, S.A.,etc.Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients[J].2013,110(41).
[5]Grover, P. K.,Cummins, A. G.,Price, T. J.,etc.Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research[J].2014,25(8).
[6]Scher HI,Tissing H,Terstappen LW,etc.Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.[J].2008,14(19).
[7]Thompson EW,Polette M,Gilles C,etc.Epithelial-to-mesenchymal transitions and circulating tumor cells.[J].2010,15(2).
[8].Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance - A study of the OVCAD consortium[J].2013,128(1).
[9]Ulrich, Andergassen,Alexandra C, K?lbl,Stefan, Hutter,etc.Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients via RT-qPCR.[J].2013,5(4).
[10]Barry,W.T.,Doyle,C.,Kindelberger,D.,etc.Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients[J].2013,131(2).
[11]Catherine Alix-Panabieres,Klaus Pantel.Technologies for detection of circulating tumor cells: facts and vision[J].2014,14(1).
[12]Chetan, Bettegowda,Mark, Sausen,Rebecca J, Leary,etc.Detection of circulating tumor DNA in early- and late-stage human malignancies.[J].2014,6.
[13]Daniel L. Adams,Stuart S. Martin,R. Katherine Alpaugh,etc.Circulating giant macrophages as a potential biomarker of solid tumors[J].2014,111(9).
[14]Martignetti, John A.,Camacho-Vanegas, Olga,Priedigkeit, Nolan,etc.Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA[J].2014,16(1).
[15]Syne,L.,Polette,M.,Bonnomet,A.,etc.A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer[J].2012,31(33).
[16]Zhang,Y.,Ma,Q.,Liu,T.,etc.Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms[J].2014,140(2).
[17]Ning Ning,Ting Zhan,Yujuan Zhang,etc.Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization[J].2014,433.
[18]Jenks, Susan.Setting the Bar Higher for Ovarian Cancer Survival[J].2014,106(2).
[19]Di-Leo A,Claudino W,Colangiuli D,etc.New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancer.[J].2007,18(Suppl.12).
[20]Natalia, Bednarz-Knoll,Catherine, Alix-Panabières,Klaus, Pantel.Clinical relevance and biology of circulating tumor cells.[J].2011,13(6).
[21]Parekh T,Wang S,Tercero JC,etc.Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer.[J].2011,122(3).
[22]Aktas B,Kasimir Bauer S,Heubner M,etc.Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.[J].2011,21(5).
[23].Molecular analysis of circulating tumour cells - Biology and biomarkers[J].2014,11(3).
[24]Amato RJ,Kularatne SA,Hartmann LC,etc.Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.[J].2008,123(8).
[25]Philip S. Low,Wei He,Lynn C. Hartmann,etc.In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry[J].2007,104(28).